Table 4. Factors Associated With Patient-Reported Outcomes at 3 Months in Multivariable Analysis.

Variable	Change in Epworth Sleepiness Scalea		Visit-Specific Satisfaction Instrument–9b
	Coefficient (95% CI)	P value	Coefficient (95% CI)	P value
Wait time to treatment	−9.37 (−18.51 to −0.24)	.04	−0.024 (−0.047 to −0.0015)	.04
Age	−40.27 (−92.63 to 12.08)	.13	−0.25 (−0.13 to 0.79)	.64
Sex	272.47 (−958.33 to 1503.27)	.66	0.73 (−2.03 to 3.48)	.60
No. of comorbidities	189.38 (−418.97 to 797.73)	.54	0.12 (−1.22 to 1.47)	.86
Cardiovascular disease	249.54 (−1481.01 to 1980.10)	.78	2.55 (−1.35 to 6.44)	.20
No. of medications	54.82 (−92.12 to 201.76)	.46	−0.17 (−0.45 to 0.11)	.24
Neuropsychiatric medication	252.59 (−783.69 to 1288.87)	.63	2.45 (0.056 to 4.85)	.05
Narcotic use	−1804.72 (−3402.73 to −206.71)	.03	−1.39 (−5.09 to 2.32)	.46
Study group	−428.36 (−1502.58 to 645.85)	.42	−1.65 (−4.13 to 0.82)	.19
Baseline
Apnea-hypopnea index on polysomnogram	−0.000083 (−0.13 to 0.13)	.99	−0.0000019 (−0.00027 to 0.00026)	.99
Respiratory event index on home sleep apnea testing	11.69 (−10.13 to 33.52)	.29	−0.0046 (−0.050 to 0.041)	.84
Epworth Sleepiness Scale score	−75.38 (−174.87 to 24.12)	.14	−0.16 (−0.43 to 0.099)	.22
Adherencec	1843.26 (736.04 to 2950.47)	.001	4.10 (1.54 to 6.66)	.002
Change in Epworth Sleepiness Scale score at 3 mo	NA	NA	−0.29 (−0.56 to −0.018)	.04

Abbreviation: NA, not applicable.

^aResults are presented for patients with complete follow-up Epworth Sleepiness Scale data (127 total; 60 in the physician group and 67 in the alternative care practitioner group).

^bResults are presented for patients with complete Visit-Specific Satisfaction Instrument–9 data (106 total; 50 in the physician group and 56 in the alternative care practitioner group).

^cAdherence was defined as positive airway pressure use for at least 4 hours on at least 70% of nights.